Review Article

Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases

Table 1

Summary of the main findings of IL-17 implication in bone loss and structural damage in animal models.

ReferencesAnimalAnimal modelTreatment/interventionMain results

[22, 23]IL-17A-/- mice
C57BL/6J mice
NAIL-17A-/- mice have physiological bone homeostasis indistinguishable from Wnt mice
[14]IL-17 overexpression
C57BL/6J mice
Systemic recombinant minicircle injectionPeripheral joint destruction without joint inflammation but some psoriasis
Systemic bone loss not studied
IL-17 overexpression
C57BL/6J mice
Collagen-induced arthritisSystemic recombinant minicircle injectionIL-17A exacerbates synovial inflammation and bone loss in inflammatory arthritis
[25]IL-17RA-/- miceOvariectomyNAProtected against bone loss
[24]Adult Balb/c miceOvariectomyAnti-IL-17 antibodyPrevented the bone loss phenotypes
[26]Adult Balb/c miceOvariectomyAnti-IL-17, anti-TNF, and anti-RANK-L antibodiesCortical bone parameters, bone biomechanical properties, and histomorphometry were best preserved by anti-IL-17 antibody
[55]Balb/c miceDefects in middiaphysis region of femurAnti-IL-17 antibodyImprovement of bone healing by recruitment of osteoprogenitors at the injury site
[20]Sprague-Dawley ratsCritical-sized defects in the calvariaDefects were filled with IL-17IL-17 significantly inhibited the filling of calvarial defects in vivo
[43]DBA/1 miceCollagen-induced arthritisAdenoviral IL-17 injected in the knee jointAccelerated the onset and aggravated the synovial inflammation at the site, enhanced osteoclastic activity
[45]DBA/1 miceCollagen-induced arthritisIL-17-deficient allogeneic bone marrow transplantationDecreased arthritis severity associated with increased functionally suppressive Tregs and reduced levels of other Th17-lineage inflammatory cytokines
[44]DBA/1 miceCollagen-induced arthritisAnti-IL-17 antibodyTreatment even after the onset of CIA significantly reduced the severity of CIA and suppressed joint damage